Cargando…
维吾尔族肺腺癌患者的EGFR基因突变分析
BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor (EGFR), a transmembrane protein, is a member of the tyrosine kinase family. Gefitinib, an EGFR tyrosine-kinase inhibitors, has shown a high response rate in the treatment of lung cancer in patients with EGFR mutation. However, significant di...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000386/ https://www.ncbi.nlm.nih.gov/pubmed/23425899 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.02.04 |